Introduction
Until relatively recently, human exposure to platinum (Pt) and Pt compounds has been limited mainly to the workplace (e.g., mining and refining and the manufacture and reprocessing of catalysts) and laboratory. However, accompanying the introduction of the automobile catalytic converter (1975 automobile model year), the therapeutic use of Pt complexes with antitumor activity (1) , and the inevitable increase in coal utilization (which, overall, portance among these is necrosis of the proximal convoluted tubules (resulting from the accumulation ofhigh levels of Pt in the kidney) which terminates in nephrosis. Destruction of the gastrointestinal epithelium also occurs and, in humans, is doselimiting. In addition, high doses of cis-dichlorodiamineplatinum(II) are ototoxic, depress bone marrow function, and induce nausea and emesis (3) (4) (5) (6) (7) (8) .
Much remains to be learned about the interactions of other types of Pt compounds with biological systems. In animal studies, it has been observed that orally administered PtC14 is poorly absorbed (less than 0.5%) (9, 10) . Of the absorbed Pt, between 50 and 70%o Pt is excreted via the urinary route; the remainder via the fecal route (9) (10) (11) . Via the intravenous route of administration, the highest levels of Pt are found in the kidney, spleen, and liver, and elimination half-times of the order of 2.5 to 7.5 days are observed (8) (9) (10) (11) . These retention/elimination characteristics appear to be similar to those of cisdichlorodiamineplatinum(II) in humans (12) .
Platinum compounds also have been shown to be allergenic in the majority of exposed industrial employees (13) . Symptoms include bronchial asthma, allergic rhinitis, eczema, itching, and dermatitis (13, 14) .
Except for cases of high sensitivity, it would appear that exposure to relatively high doses of Pt is required to elicit overt toxicity. However, it is of considerable importance to be cognizant of the fact that long-term, low-level (classically subpharmacological) exposure to environmentally available toxicants may result, in an insidious manner, in covert toxicity manifested, for example, by behavioral alteration (15, 16) . In this context, nothing is known about Pt compounds.
Thus, employing the mouse as a model mammalian system, we undertook to investigate the effects of acute and repeated (subacute) exposure to Pt (sulfate) on: tissue/organ uptake of Pt, selected behaviors (open field, exploratory), and the relationship between tissue/organ Pt levels and behavioral effects.
Materials and Methods

Animals
Male random-bred Swiss mice (ICR strain, West Seneca Laboratories, West Seneca, NY) 6-8 weeks old, served as subjects in all studies. The animals were acclimated to the laboratory for at least one week prior to use. For all experiments except the dose determination study, they were housed individually in suspended metal mouse cages (Hoeltge, Inc., Cincinnati, Ohio). For the dose determination study, the animals were maintained in groups of five per double cage. All were fed ad libitum on Subjects in this study were 160 animals.
The 7-day LD5 and LD25 were selected for investigation. At these concentrations, the pH of the Pt(SO4)2 solutions was approximately 1.0. To compensate for possible effects of simultaneous exposure to low pH and sulfate, a low pH sulfate control (containing no Pt) was included in the study. The sulfate concentration and pH of this solution were identical to those of the LD25 dose. To identify possible effects on behavioral performance of exposure to low pH and sulfate, a saline control group also was investigated. Thus 
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In an extensive pilot study, it was established that the tissue Pt levels of animals not receiving Pt were below the detection limit of the assay. Therefore, only the tissues of Pt group animals were analyzed. Tissues of the Pt group animals were analyzed by flaneless atomic absorption spectroscopy employing a wet ashing procedure modified that described by Tillery (17) . Samples were collected in acid washed test tubes. Concentrated nitric acid, 5 ml, was added, and the samples were heated to 70°C to initiate digestion of the tissues. The nitric acid was boiled off and 5 ml concentrated HCl was added and boiled off; 2 ml of70%o perchloric acid was added and heated to approximately 200°C to complete digestion. The perchloric acid was boiled off, and a Pt-Sn complex was formed by the addition of a 2% stannous chloride solution in 3M HCl. The negatively charged complex was extracted with two 0.5 ml aliquots of 20 mM tri-n-octylamine in xylene. Extraction was necessary to obtain Pt free of interferring inorganic salts present in the tissues. Platinum levels were measured on a Perkin-Elmer Model 360 atomic absorption spectrophotometer equipped with a Model HGA-2100 graphite furnace. A 25 IlI aliquot of the sample in xylene solution was placed in the graphite furnace. The sample was dried at 160°C, charred at 900°C, and atomized at 2700°C. Samples were compared to a standard curve included in each run, obtained from aqueous standards extracted into xylene in the same manner as the samples.
Analyses of variance (ANOVA) and overall association and correlation analyses were performed by using the Multivariance Computer Program, version 5.3 (18) . Simple effects were investigated using Tukey's Honestly Significant Difference Test perfonned by the Statistical Package for the Social Sciences (SPSS) version 6.0, subprogram one way (19) .
Lethal dose percentiles (LD..) and confidence intervals were obtained by probit analysis (18) using an Isobol computer program (20) .
Exploratory Behavior. Subjects were 160 male mice. Dosing was performed as described above in the Pt(S04)2 single-dose open field study.
Behavioral observation was carried out by placing the subjects in a 5.7 cm wide circular runway formed from two concentric walls with an outside diameter of 34.3 cm. In the outside wall were four holes, 1.3 cm in diameter, centered 900 apart and 5.1 cm above the floor. Photocells were so arranged that each time the animal placed its snout into a hole the event was counted. Thus, the measure of exploratory behavior was the number of hole entries (automatically recorded) in a 5 min period. The runway was especially designed to minimize general activity and maximize exploratory activity. Subjects were 250 animals. Of these, 100 animals (plus an allowance for probable deaths) were assigned (randomly) both to the Pt and low pH groups, while 50 (plus an allowance) were assigned to the saline control group.
The experimental animals received 1 to 10 doses (IG) of Pt at the 7 day LD1 level of 109 mg Pt/kg in a volume equivalent to 1% (v/w) of body weight. Low pH controls received an equal volume of 0. 15M H2SO4 adjusted to pH 1.18 with NaOH (which was identical in sulfate concentration and pH to the Pt solution). Saline controls received an equivalent volume of 0. 14M NaCl. Three days after administration, ten animals each from the Pt and low pH groups and five animals from the saline group were randomly selected and observed for behavioral alterations. The remaining animals were dosed again as described and this procedure was repeated for a total of ten dosings.
The animals were observed in the automated open field and the exploratory apparatus as in the single dose studies described above. Half of the animals in each treatment group were observed first in the open field and then in the exploratory apparatus. With the other half, the procedure was reversed.
Immediately following behavioral observation after doses 2, 4, 6, 8, and 10, the Pt group animals were sacrificed and a blood sample, the liver, kidneys, spleen, lung, gastrointestinal tract, testes, and brain were collected in acid-washed test tubes. Tissue Pt concentrations were determined as described above.
Results
Exposure to a Single Dose of Pt (SO4) Environmental Health Perspectives tests for interactions of the two main effects (time and treatment) that are not simply additive, was not statistically significant. To determine the basis of the time and treatment effects, the behavioral data ( Fig. 1) were subjected to Tukey's Honestly Significant Difference Test (19) . The time effect for ambulations was found to be due to the 4 hr animals having lower scores than the 1-day animals. However, neither of these groups differed significantly from the 3-or 7-day groups. The treatment effect for ambulations was due to the LD25 groups having lower scores than all other treatment groups (which did not differ among themselves). For rearings, the treatment effect only approached significance. However, the pattern for rearings paralleled that for ambulations.
Tissue/organ Pt concentrations (for the Pt groups only) were subjected to a multivariate ANOVA cerebellum had significant univariate effects.
( Table 2 ). There was a significant multivariate time The effects of time and dose on tissue/organ Pt effect with significant univariate effects for all tis-concentrations are shown in Table 3 . It is apparent sues except spleen. The multivariate dose effect also that there is a time differential in the attainment of was significant with significant univariate effects for maximum Pt levels among different tissues/organs. all tissues except brain. The multivariate time by Thus, Pt concentrations in the blood, kidney, lung, dose interaction was significant; but only muscle and muscle, and brain tissue are highest at 4 hr post The time by treatment interaction primarily appears to be due to the 4 hr low pH control group which explored significantly more than the 4 hr Pt treated or saline control groups. In fact, all groups were similar at 4 hr with the exception of the low pH group. The balance of the interaction is taken up by the fact that exploratory behavior decreased at 1, 3, and 7 days for all groups except the saline control group whose behavior remained constant across time.
Exposure to Multiple (Repetitive) Doses of Pt(SO4)2 at the LD1 Level Open Field and Exploratory Behavior. The means (+ SD) for the three behavioral measures (ambulations, rearings and explorations) are presented in Table 5 . Multivariate ANOVA of these data (Table 6 ) revealed a significant effect of dose number with rearings as the only significant univariate measure. The treatment effect approached significance (p < 0.07) with significant univariate F-ratios for ambulations and explorations. The doses by treatment interaction also approached significance with a significant univariate effect for rearings and with explorations approaching significance. Tukey's Hones,tly Significant Difference procedure revealed that rearings were depressed following doses 7, 8, 9, and 10 compared to dose 2 and were also depressed following doses 7 and 8 compared to dose 3. Tukey's procedure is not entirely efficient for unequal cell frequencies and failed to find any pairwise differences among treatments for ambulations and explorations despite significant overall F-ratios. Therefore, linear combinations of the treatments (Pt vs. low pH and saline, and low pH-vs. saline) were tested as t-statistics to locate the effect. Ambulations and explorations were found to be depressed in the Pt groups relative to the control groups by this procedure while the control groups did not differ. The time by treatment interaction for rearings arose because, at times 7 and 10, scores for the Pt groups were lower than those for the saline controls. The time by treatment interaction for explorations arose because at time 10 only, the Pt group scores were lower than those of both control groups.
Tissue/Organ Pt Levels Following Exposure to Multiple (Repetitive) Doses of Pt(S04)2 at the LDl Level. Tissue/organ Pt levels were analyzed by Table 8 .
relative to the tissue levels following exposure to a A significaiit overall association was found. Howsingle dose at the LD5 level. We have no explanation ever, the only individual behavioral measure signifi-for this observation. However, it is conceivable that Environmental Health Perspectives the higher Pt dose may damage or stress the GI tract in some manner, resulting in increased Pt absorption. Alternatively, or in addition, the higher Pt concentrations found in the blood and kidneys of animals dosed at the higher level may damage the kidneys [which normally appear to eliminate Pt quite efficiently (21, 22) ], resulting in decreased Pt excretion. Furthermore, it is well known that some metals, such as cadmium and lead, bind to proteins and in some cases (e.g., Cd) induce the synthesis of their own binding proteins (23, 24) . Platinum may function similarly.
Acute exposure to Pt(SO4)2 significantly depressed ambulations in the open field and marginally depressed rearings (but only at the LD25 dose level). For ambulations, this pattern persisted from 4 hr through 7 days after administration, although the effect was most pronounced at 4 hr (Fig. 1) . A correlation analysis ( 10 doses, was substantially greater than the 7 day LD5o. In this study, tissue Pt levels: were found to be low across doses, were highly variable among tissues, and generally increased with dose number, except for the brain in which no Pt was detected ( Table 7) . The absence of Pt in the brain is not surprising since the highly charged Pt cation should be excluded by the bloodbrain barrier.
Analysis of variance of the open field and exploratory behavioral measures obtained in the multiple dose study indicated a significant multivariate effect of dose. The multivariate effects of treatment and the doses by treatment interaction approached significance, and a number of the univariate F-ratios were significant (Table 6 ). Relative to dose, there was a highly significant difference in rearings between control and experimental animals. Also, rearings showed significant negative correlations with tissue Pt levels ( Table 8 ). In light of the very low tissue/organ Pt levels (Table 7) , these observations would appear to be highly significant.
A comparison of the single and multiple dose studies indicates a consistent relationship between the tissue/organ Pt levels and behavior (particularly rearings). In the single dose study, relatively high tissue Pt levels were associated with strongly significant behavioral effects while in the multiple dose study, relatively low tissue Pt levels were associated with weak behavioral effects. In both cases, the correlations between tissue Pt levels and rearings were generally significant, with the notable exception of the brain. Since these correlations involved a number of tissues, but not the brain, a general systemic effect, rather than a neurotoxic effect, seems to be indicated. Pt compounds have been shown to inhibit DNA, RNA, and protein synthesis in vitro (25) and in vivo (1, 21) . Our findings suggest that Pt has a depressing effect on cellular processes and exposure to Pt above a threshold level results in general malaise which is manifested as a depression of certain behaviors. As Pt levels increase, the interference with cellular processes and, therefore, behavioral depression is likewise increased.
In summary, Pt(SO4)2 administered via the IG route appears to be poorly absorbed. However, with the exception of brain tissue, the absorbed Pt achieves general systematic distribution. With repeated exposure, tissue concentrations tend to increase with dose; again, with the exception of brain which did not accumulate Pt. While Pt did affect behavior under conditions of single and multiple dose exposure, these effects were weak except when very high (LD25) individual doses were employed. In the latter case, the behavioral effects were more pronounced and lasted for up to 7 days post admin-istration (end ofobservation). The consistent pattern of relationship between tissue levels of Pt and behavior is suggestive of interference with cellular processes induced by Pt at concentrations greater than some threshold value. This interference is manifested as behavioral malaise.
It is difficult to predict the potential danger of increased anthropogenic redistribution of Pt in the environment. Toxicity has been observed in humans exposed to high Pt levels in the workplace or during antitumor chemotherapy. However, such dose levels are many times those that would ever be expected to occur in the general environment. Nevertheless, since exposure to Pt appears to alter certain behavior of the mouse, tOe possibility of subtle adverse biological and behavioral effects resulting from long-term low levei (environmental) exposure of humans cannot be disregarded especially in the light of the fact that Pt can be methylated (26) in a manner analagous to that of mercury (27) . By altering its physicochemical properties, methylation may, as in the case of mercury (28) greatly enhance the toxicity of Pt and its bioaccumulatability.
